Showing results (471-480 of 496) with videos related to
Sort By:
Pageof 50
Biotechnology Reports (Amsterdam, Netherlands)|January 29, 2026
Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint DiseaseValentina Varela, Monique Costa, Cecilia Maciel, et al.Alimentary Pharmacology & Therapeutics|December 21, 2000
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosisP L Almasio, A Floreani, M Chiaramonte, et al.International Journal of Cancer|October 9, 1996
Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypesG Masala, S Di Lollo, C Picoco, et al.Human Reproduction (Oxford, England)|October 2, 2004
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1BS Bione, F Rizzolio, C Sala, et al.European Journal of Cancer (Oxford, England : 1990)|February 19, 2010
What reasons lie behind long-term survival differences for gastric cancer within Europe?Anne-Marie Bouvier, Milena Sant, Arduino Verdecchia, et al.Tumori|June 14, 2005
National estimates of cancer patients survival in Italy: a model-based methodRiccardo Inghelmann, Enrico Grande, Silvia Francisci, et al.Epidemiology (Cambridge, Mass.)|August 1, 2006
Occupational exposure to solvents and the risk of lymphomasLucia Miligi, Adele Seniori Costantini, Alessandra Benvenuti, et al.American Journal of Industrial Medicine|July 25, 2008
Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control studyAdele Seniori Costantini, Alessandra Benvenuti, Paolo Vineis, et al.Gut|November 13, 2002
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient dataC Cammà, S Bruno, F Schepis, et al.Pageof 50